Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) Polyclonal Antibody

Size

10 μg

Catalog no#

CAU28487

Price

174 EUR

Tissue

tumor

Use before

1 year

Raised in

Rabbit

Shipping requirements

Blue ice

French translation

anticorps

Antibody's concentration

200μg/ml

Clonality

Polyclonal

Protein number

Please see Uniprot

Estimated production time

7-11 business days

Immunogen

TRAIL (Thr36~Gly281)

NCBI number

Please refer to NCBI

Gene number

Please refer to GenBank

Group

Polyclonals and antibodies

Verified applications

WB, ICC, IHC-P, IHC-F, ELISA

Verified reactivity

Canis familiaris; Canine (Dog)

Purity

Affinity purified. Please contact us for more details

Notes

For research use only. Not for diagnostic procedures.

Supplementary information

Applicable secondary antibody is available. Please inquire

Storage recommendation

Aliquot and store at -20°C. Minimize freezing and thawing.

Other name

CD253; TNFSF10; APO2L; Apo2-L; TL2; TRAIL; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand

Properties

If you buy Antibodies supplied by bioma they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

About

Polyclonals can be used for Western blot, immunohistochemistry on frozen slices or parrafin fixed tissues. The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera.

Description

This 1 is suited for programmed cell-death studies.Aplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells.FAS ligand and other ligands are binding to the receptor for signaling pathways for example in apoptosis or JNK signaling. Receptor agonists are often tested for drug development.